Therapeutic Applications of Magnetotactic Bacteria and Magnetosomes: State-of-the-Art and Perspectives
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Biophysics".
Deadline for manuscript submissions: 25 December 2024 | Viewed by 26
Special Issue Editor
Interests: apoptosis; autophagy, mitochondria, proteins/lipids interactions in cell death signaling and experimental toxicology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are glad to invite you to participate in the following new topics:
Magnetotactic bacteria biomineralize magnetosomes, which are defined as intracellular nanocrystals of the magnetic minerals, magnetite (Fe₃O₄) or greigite (Fe₃S₄) enveloped by a phospholipid bilayer membrane. The synthesis of magnetosomes is controlled by a specific set of genes that encode proteins, some of which are exclusively found in the magnetosome membrane.
Over the past decade, interest in nanotechnology and biotechnology of the magnetotatic bacteria has increased significantly, and their advantages in biomedical sciences has developed rapidly.
One excellent example of a biological nanomaterial that is showing great promise for use in a large number of commercial and medical applications are bacterial magnetite magnetosomes. Unlike chemically synthesized magnetite nanoparticles, magnetosome magnetite crystals are stable single-magnetic domains and are thus permanently magnetic at ambient temperature, are of high chemical purity, and display a narrow size range and consistent crystal morphology. These physical/chemical features are important in their use in biotechnological and other applications as well medical uses. We wanted to encourage the submission of any article that describe magnetite-producing MTB, magnetite magnetosomes and/or magnetosome magnetite crystals, include and/or involve bioremediation, cell separation, DNA/antigen recovery or detection, drug delivery, enzyme immobilization, magnetic hyperthermia and contrast enhancement of magnetic resonance imaging for biomedical usages.
Dr. Patrice X. Petit
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biomedical applications
- biotechnology
- magnetite nanocrystals
- magnetosomes
- magnetotactic bacteria
- nanotechnology
- nanotargeting
